FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/061774 [Registered on: 23/01/2024] Trial Registered Prospectively
Last Modified On: 05/02/2024
Post Graduate Thesis  No 
Type of Trial  PMS 
Type of Study   Other (Specify) [Cosmetics ]  
Study Design  Single Arm Study 
Public Title of Study   Effectiveness of 24-hours moisturization potential of Avimee moisturizing lotion 
Scientific Title of Study   A Clinical Study to evaluate the 24-hours moisturization potential of Avimee Padmini moisturizing lotion. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
CCFT152 Version 1.0 dated 18 Dec 2023  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Robin Chugh 
Designation  Principal Investigator  
Affiliation  CCFT Laboratories  
Address  1st Floor room 3, Skin testing lab ,CCFT laboratories, AR multispecialty hospital and research center, Delhi Road

Meerut
UTTAR PRADESH
250002
India 
Phone  7078103723  
Fax    
Email  robinderm25@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Puneet Mittal  
Designation  Clinical Research Consultant 
Affiliation  CCFT Laboratories  
Address  1st Floor room 3, Skin testing lab ,CCFT laboratories, AR multispecialty hospital and research center, Delhi Road

Meerut
UTTAR PRADESH
250002
India 
Phone  8937015757  
Fax    
Email  puneetmittal@mgcts.org  
 
Details of Contact Person
Public Query
 
Name  Puneet Mittal  
Designation  Clinical Research Consultant 
Affiliation  CCFT Laboratories  
Address  1st Floor room 3, Skin testing lab ,CCFT laboratories, AR multispecialty hospital and research center, Delhi Road


UTTAR PRADESH
250002
India 
Phone  8937015757  
Fax    
Email  puneetmittal@mgcts.org  
 
Source of Monetary or Material Support  
Avimee Herbal Pvt. Ltd. 422/2 F Building, GIDC Pandesara, Surat 394221 Gujrat 
CCFT Laboratories, 135, Punjabipura, Delhi Road, Meerut, India  
 
Primary Sponsor  
Name  Avimee Herbal Pvt. Ltd. 
Address  422 by 2 F Building, GIDC Pandesara, Surat 394221 Gujrat 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
Not applicable   Not applicable  
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Robin Chugh  CCFT laboratories   1st Floor room 3, Skin testing lab ,CCFT laboratories, AR multispecialty hospital and research center, Delhi Road Meerut Meerut Uttar Pradesh 250002 India Meerut UTTAR PRADESH 250002 Meerut UTTAR PRADESH Meerut UTTAR PRADESH
Meerut
UTTAR PRADESH 
7078103723

robinderm25@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ARMHRC Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Not Applicable  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Not Applicable  Not Applicable 
Intervention  Test Product: Avimee Padmini moisturizing lotion  Dose: Gently massage approx. 1 drop of moisturizing lotion over one block as assigned (forearm) Route of Administration: Topical Duration: 24 hour 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1. Gender: Male or Female 18 to 50
2. Subjects willing to give written informed consent
3. Women of childbearing potential must have a negative urine pregnancy test prior to study entry.
4. Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
5. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.
 
 
ExclusionCriteria 
Details  1. Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
3. Have open sores or open lesions in the treatment area.
4. Have any condition that, in the opinion of the investigator, would confound the safety and or efficacy assessments of the product.
5. Have participated in any interventional clinical trial in the previous 90 days.
6. Have a known sensitivity to any of the constituents of the test product
7. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
8. Have not skin related issues  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in Moisture  T0min, T+30 mins, T+ 2 hours, T+4 hours, T+ 6 hours, T+8 hours , T+ 24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
Not Applicable  Not Applicable 
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   27/01/2024 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="0"
Days="10" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The below product would be tested as per the guideline IS4011 for dermal safety assessment.
1. Padmini Moisturising Lotion. 
Test Product- Avimee Padmini Moisturizing lotion
Dose: Gently massage approx. 1 drop of Moisturizing lotion over one block as assigned (forearm) Route of Administration: Topical Duration: 24 hour


 
Close